313 related articles for article (PubMed ID: 38214)
1. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
Lammintausta R; Koulu M; Allonen H
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of labetalol in man.
Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
Koch G
Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Pandhi P; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
[TBL] [Abstract][Full Text] [Related]
6. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
7. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
[TBL] [Abstract][Full Text] [Related]
8. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
10. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):729-32. PubMed ID: 10951
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
12. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
[TBL] [Abstract][Full Text] [Related]
13. Alpha- and beta-adrenoceptor blockade does not affect ventilation during exercise in man.
Fagard R; Reybrouck T; Lijnen P; Amery A; Moerman E; De Schaepdryver A
Med Sci Sports Exerc; 1980; 12(5):375-9. PubMed ID: 6109223
[TBL] [Abstract][Full Text] [Related]
14. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma concentrations and pharmacological effects of labetalol.
Richards DA; Maconochie JG; Bland RE; Hopkins R; Woodings EP; Martin LE
Eur J Clin Pharmacol; 1977 Jan; 11(2):85-90. PubMed ID: 14010
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
17. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of labetalol in healthy volunteers.
Allonen H; Kanto J; Pakkanen A; Wendelin H
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):517-9. PubMed ID: 7174154
[TBL] [Abstract][Full Text] [Related]
19. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
[TBL] [Abstract][Full Text] [Related]
20. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]